drugset / Trial / NCT05208034
Medical Treatment in Ectopic Tubal Pregnancy
RandomizedParallel-groupOpen-labelTreatment
Summary
Ectopic pregnancy (EP) is estimated to be responsible for approximately 20% of all pregnancy-related mortality and 46% early pregnancy mortality.1 Hemodynamically stable women with EP are frequently managed with methotrexate (MTX) while multiple protocols like fixed multiple doses, single-dose as well as two-dose regimens have been in practice for treating EP, but no consensus exists regarding the optimum dosage regimen.
Timeline
- Start
- 2020-01-01
- Primary completion
- 2021-07-30
- Completion
- 2021-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methotrexate | Small molecule | 50 mg/m2 | Intramuscular |